A retro-reflector is a device or surface that is capable of reflecting light back to its source with minimal scattering. UA’s Russell Chipman, Ph.D., and Karlton Crabtree, Ph.D., created a novel design for a retro-reflector that increases the reflection efficiency while reducing the complexity of the system.

The University of Arizona has licensed a new tunable laser technology invented in the College of Optical Sciences to startup TPhotonics, Inc. The technology allows for devices that can produce a beam and tweak its wavelength on-the-fly.

In recognition of his prolific work as an impactful innovator and educator, optical sciences professor Nasser Peyghambarian, Ph.D. has been elected as a 2017 Fellow of the National Academy of Inventors. Read more. >

What do you need for a successful commercialization ecosystem? First, you need great inventions, such as those stemming from UA research. But just as important, you need great, experienced, committed people – lots of them – to provide the right expertise at the right time.

The most common method of managing pain is the use of opioids like morphine, oxycodone, and fentanyl, all of which are highly addictive. Research has shown that therapeutic exposure to low-intensity green light can reverse chronic pain.

The University of Arizona has exclusively licensed the rights to a novel kinase inhibitor, which is efficacious for the treatment of a variety of solid tumors in canines, to Anivive Lifesciences.

At the Get Started Tucson business pitch competition, judges selected just eight teams out of a pool of 69 applicant companies to pitch at the Tucson version of ABC’s Shark Tank. Of those, two were companies working to commercialize technologies invented at the UA.

Cryptosporidium is a protozoan parasite that lives in the intestine and is a major cause of moderate-to-severe diarrhea in humans and livestock worldwide. Michael Riggs, DVM, PhD, DACVP, has developed monoclonal antibodies capable of detecting Cryptosporidium antigens.

UA researchers, in collaboration with the University of California San Francisco, have developed a new treatment for acute myeloid leukemia. The team has formed a startup – Promutech Pharmaceuticals, Inc. – to further develop and commercialize the treatment.

The UA, through TLA, has partnered with TechCode, a global network of startup incubators and entrepreneurial ecosystems. TechCode will provide networking resources to increase the reach and effectiveness of TLA’s technology innovations and startups.